Natural Killer Cell Recognition and Control of Epithelial Cancers
Open Access
- 25 July 2022
- journal article
- review article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 28 (4) , 263-269
Abstract
Natural killer (NK) cells possess an innate ability to recognize cancer and are key mediators of cytotoxic efficacy for anticancer antibodies. Recent advances in the ability to generate, qualify, and safely infuse NK cells have led to a wide variety of clinical trials in oncology. Although their efficacy is best established for liquid cancers, their potential application in solid cancers has received increased attention. Here, we provide general background across a disparate group of exemplary solid tumors for which there is evidence for an NK cell role, discuss NK cell recognition motifs specific to each and murine and human studies of each that are supportive of NK cell adoptive immunotherapy, and end with special considerations relevant to the solid tumor microenvironment.Keywords
This publication has 101 references indexed in Scilit:
- Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironmentJournal of Clinical Investigation, 2013
- Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patientsCancer Immunology, Immunotherapy, 2012
- R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt AxisPLOS ONE, 2011
- Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cellsCancer Immunology, Immunotherapy, 2011
- KIR receptor‐ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cellsPediatric Blood & Cancer, 2010
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for NeuroblastomaNew England Journal of Medicine, 2010
- The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapyBritish Journal of Cancer, 2010
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- Review of the activation of TGF-β in immunityJournal of Leukocyte Biology, 2008
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987